Loading live market data…

Clearside Biomedical, Inc.

NASDAQ:CLSD

$0.41 USD

$0 (0.0%)

Volume
2.05M
Average Volume
264.4K
Market Capitalization
$2.15M
P/E Ratio
-0.11
Dividend Yield
0.00%
Price Target
$
Year High
$17.10
Year Low
$0.31
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.98

CLSD Estimated and Actual Revenue by Quarter

CLSD Estimated and Actual EPS by Quarter

CLSD Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2026-12-30 1 -159.25K -159.25K -159.25K -159.49K -159.49K -159.49K
2026-09-30 1 -159.25K -159.25K -159.25K -159.49K -159.49K -159.49K
2026-06-30 1 -159.25K -159.25K -159.25K -159.49K -159.49K -159.49K
2026-03-30 2 -159.25K -159.25K -159.25K -159.49K -159.49K -159.49K
2025-12-30 3 -342.65K -342.65K -342.65K -343.17K -343.17K -343.17K
2025-09-30 4 -103.61K -44406 -76971 -103.77K -44473 -77087
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2026-12-30 1 -6.28M -6.28M -6.28M 766.6K 766.6K 766.6K
2026-09-30 1 -6.28M -6.28M -6.28M 766.6K 766.6K 766.6K
2026-06-30 1 -7.07M -7.07M -7.07M 766.6K 766.6K 766.6K
2026-03-30 2 -7.07M -7.07M -7.07M 766.6K 766.6K 766.6K
2025-12-30 3 -3.14M -3.14M -3.14M 1.65M 1.65M 1.65M
2025-09-30 4 -4.34M -2.17M -3.23M 213.76K 498.78K 370.52K
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2026-12-30 1 200K 200K 200K 1 -1.2 -1.2 -1.2
2026-09-30 1 200K 200K 200K 1 -1.2 -1.2 -1.2
2026-06-30 1 200K 200K 200K 1 -1.35 -1.35 -1.35
2026-03-30 2 200K 200K 200K 1 -1.35 -1.35 -1.35
2025-12-30 3 430.33K 430.33K 430.33K 1 -0.6 -0.6 -0.6
2025-09-30 4 55769 130.13K 96667 1 -0.83015 -0.41507 -0.618